Clinical and laboratory studyBorrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America☆
References (18)
- et al.
Is localized scleroderma a Borrelia infection? [Letter]
Lancet
(1985) - et al.
Detection of human immunodeficiency virus-DNA and RNA in the skin of HIV-infected patients using the polymerase chain reaction
J Invest Dermatol
(1991) - et al.
Herpes simplex virus DNA in occult lesions: demonstration by the polymerase chain reaction
J Am Acad Dermatol
(1991) - et al.
Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confimed by DNA amplification
J Invest Dermatol
(1993) - et al.
Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chromicum migrans but not in circumscribed scleroderma lesions
J Invest Dermatol
(1994) - et al.
Terminal transferase: use in the tailing of DNA and for in vitro mutagenesis
Methods Enzymol
(1983) - et al.
Localized scleroderma (morphea) and antibody to Borrelia burgdorferi
J Am Acad Dermatol
(1987) - et al.
Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans
J Invest Dermatol
(1994) - et al.
No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma
J Invest Dermatol
(1995)
There are more references available in the full text version of this article.
Cited by (0)
- ☆
Presented at the Society for Investigative Dermatology annual meeting, Washington, D.C., April 28–May 1, 1993.
- ∗
Dr. Dillon received a grant from the Henry Ford Hospital Medical Education Resident Research Award.
Copyright © 1995 Published by Mosby, Inc.